Anixa (ANIX) CEO Amit Kumar Buys 3,000 Shares

What Happened
Amit Kumar, CEO of Anixa Biosciences (ANIX), reported a purchase of 3,000 shares on July 24, 2026. The shares were acquired at $3.73 each for a total of $11,190. This was a purchase (insider buying), which some investors view as a positive signal; the filing itself is factual and does not state motivation.

Key Details

• Transaction date: 2026-07-24; filing date: 2026-07-27 (Form 4 accession 0001493152-26-034723).
• Transaction type/code: Purchase (P) — open market or private purchase as reported.
• Price and value: 3,000 shares × $3.73 = $11,190 total.
• Shares owned after transaction: Not specified in the details provided.
• Footnotes/plans: No 10b5-1 plan, tax withholding, or other footnotes reported in the supplied transaction info.
• Timeliness: Filed within the normal reporting window (filed July 27), so not a late disclosure.

Context
Insider purchases are often watched by retail investors as a potential sign of confidence, but the reported purchase here is relatively small in dollar terms. This Form 4 simply documents the transaction; it does not provide reasons for the purchase or predict future company performance.